Hemophagocytic syndrome associated with antiepileptic drug

Pediatric Neurology

Volumn 30, Issue 5, 2004, Pages 358-360

  Yang, Yu Chun ^a   Jou, Shiann Tarng ^a   Chang, Yue Hiang ^a   Liang, Jao Shwann ^a   Lee, Wang Tso ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; IMMUNOGLOBULIN; LAMOTRIGINE; STEROID; VALPROIC ACID;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; EPILEPSY; HEMATOLOGY; HEMOPHAGOCYTIC SYNDROME; HUMAN; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; PANCYTOPENIA; PORENCEPHALY; PRIORITY JOURNAL; RASH; SCHOOL CHILD; TONIC CLONIC SEIZURE; TREATMENT WITHDRAWAL;

ANTICONVULSANTS; CHILD; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; MALE; TRIAZINES;

EID: 2542452881     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2003.12.012     Document Type: Article

References (15)

1. Favara B. Hemophagocytic lymphohistiocytosis A hemophagocytic syndrome. Semin Diagn Pathol. 9:1992;63-74
2. Lambotte O., Costedoat-Chalumeau N., Amoura Z., Piette J.C., Cacoub P. Drug-induced hemophagocytosis. Am J Med. 112:2002;592-593
3. Manonmani V., Wallace S.J. Epilepsy with myoclonic absences. Arch Dis Child. 70:1994;288-290
4. Nicholson R.J., Kelly K.P., Grant I.S. Leucopenia associated with lamotrigine. BMJ. 310:1995;504
5. De Camargo O.A., Bode H. Agranulocytosis associated with lamotrigine. BMJ. 318:1999;1179
6. Wong I.C., Lhatoo S.D. Adverse reactions to new anticonvulsant drugs. Drug Saf. 23:2000;35-56
7. Spielberg S.P., Gordon G.B., Blake D.A., Goldstein D.A., Herlong H.F. Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med. 305:1981;722-727
8. Leach M.J., Marden C.M., Miller A.A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug II. Neurochemical studies on the mechanism of action. Epilepsia. 27:1986;490-497
9. Messenheimer J., Mullens E.L., Giorgi L., Young F. Safety review of adult clinical trial experience with lamotrigine. Drug Saf. 18:1998;281-296
10. Guberman AH, Besag FM, Brodie MJ, et al. Lamotrigine-associated rash: Risk/benefit consideration in adults and children. Epilepsia 1999;40:985-91
11. Stanley J., Fallon-Pellicci V. Phenytoin hypersensitivity reaction. Arch Dermatol. 114:1978;1350-1353
12. Rawanduzy A, Sarkis A, Rovit RL. Severe phenytoin-induced bone marrow depression and agranulocytosis treated with human recombinant granulocyte-macrophage colony-stimulating factor: Case report. J Neurosurg 1993;79:121-4
13. Mataringa M.I., May T.W., Rambeck B. Does lamotrigine influence valproate concentrations? Ther Drug Monit. 24:2002;631-636
14. Anderson G.D. Children versus adults pharmacokinetic and adverse-effect differences. Epilepsia. 43:2002;53-59
15. Maggs J.L., Naisbitt D.J., Tettey J.N., Pirmohamed M., Park B.K. Metabolism of lamotrigine to a reactive arene oxide intermediate. Chem Res Toxicol. 13:2000;1075-1081